Long treatment periods may be required for complete remission, and it is frequently necessary to use reducing dose regimes to prevent recurrence. The use of dopamine agonists (bromocriptine, cabergoline), which produce a rapid and prolonged inhibition of prolactin secretion, may be used in persistent cases. | Long treatment periods may be required for complete remission, and it is frequently necessary to use reducing dose regimes to prevent recurrence. The use of dopamine agonists (bromocriptine, cabergoline), which produce a rapid and prolonged inhibition of prolactin secretion, may be used in persistent cases. |